An Overview of ASCP
The American Society of Clinical Psychopharmacology (ASCP) was founded in 1992 to advance the science and practice of clinical psychopharmacology. Its nearly 800 members are physicians who study and practice psychopharmacology, as well as doctoral level investigators of clinical psychopharmacology or of pharmacology. ASCP members are advocates for clinical psychopharmacology and for clinical research.
ASCP has a about 800 members, most of whom live in the United States. It is headquartered in Brentwood, Tennessee. The Society has 3 major meetings per year. The fall Update on Psychopharmacology: State of the Art brings together a number of outstanding psychopharmacologists to speak to and dialogue with meeting participants. NCDEU, which for over 50 years has featured emerging research to the field, brings together over 1200 academic and industry investigators, research pharmacists, and clinicians. Finally, ASCP co-sponsors (with NIMH and The Zucker Hillside Hospital) an annual Workshop on Clinical Trials, an intensive 2 day workshop on the “how to” of designing and running clinical trials.
ASCP’s official journal is the Journal of Clinical Psychiatry, with the largest circulation in psychiatry. ASCP also partners with Biological Therapies in Psychiatry, and members receive a discounted rate on this excellent newsletter.
Because education is a primary focus of the society, ASCP has developed a Model Curriculum in Psychopharmacology for Psychiatry Residency Training. The Curriculum is now in its 8th edition, and is widely used in the United States and internationally. A version for medical student educators and a primary care version were recently released.
ASCP invites you to learn more about our Society and programs by exploring this web site, and invites you to attend one or more of our excellent meetings.